JP2024532784A5 - - Google Patents

Info

Publication number
JP2024532784A5
JP2024532784A5 JP2024508548A JP2024508548A JP2024532784A5 JP 2024532784 A5 JP2024532784 A5 JP 2024532784A5 JP 2024508548 A JP2024508548 A JP 2024508548A JP 2024508548 A JP2024508548 A JP 2024508548A JP 2024532784 A5 JP2024532784 A5 JP 2024532784A5
Authority
JP
Japan
Prior art keywords
seq
sequence
rna
nos
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024508548A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024532784A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/074941 external-priority patent/WO2023019269A2/en
Publication of JP2024532784A publication Critical patent/JP2024532784A/ja
Publication of JP2024532784A5 publication Critical patent/JP2024532784A5/ja
Pending legal-status Critical Current

Links

JP2024508548A 2021-08-13 2022-08-12 新規なomni-115、124、127、144~149、159、218、237、248、251~253及び259crisprヌクレアーゼ Pending JP2024532784A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163232723P 2021-08-13 2021-08-13
US63/232,723 2021-08-13
PCT/US2022/074941 WO2023019269A2 (en) 2021-08-13 2022-08-12 Novel omni 115, 124, 127, 144-149, 159, 218, 237, 248, 251-253 and 259 crispr nucleases

Publications (2)

Publication Number Publication Date
JP2024532784A JP2024532784A (ja) 2024-09-10
JP2024532784A5 true JP2024532784A5 (cg-RX-API-DMAC7.html) 2025-08-20

Family

ID=85201029

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024508548A Pending JP2024532784A (ja) 2021-08-13 2022-08-12 新規なomni-115、124、127、144~149、159、218、237、248、251~253及び259crisprヌクレアーゼ

Country Status (9)

Country Link
US (1) US20240376453A1 (cg-RX-API-DMAC7.html)
EP (1) EP4384610A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024532784A (cg-RX-API-DMAC7.html)
KR (1) KR20240045285A (cg-RX-API-DMAC7.html)
CN (1) CN118103503A (cg-RX-API-DMAC7.html)
AU (1) AU2022325958A1 (cg-RX-API-DMAC7.html)
CA (1) CA3228373A1 (cg-RX-API-DMAC7.html)
IL (1) IL310732A (cg-RX-API-DMAC7.html)
WO (1) WO2023019269A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230142740A (ko) 2021-02-08 2023-10-11 에멘도바이오 인코포레이티드 Omni-103 crispr 뉴클레아제
US12091688B2 (en) 2021-02-08 2024-09-17 Emendobio Inc. OMNI-103 CRISPR nuclease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018081728A1 (en) * 2016-10-31 2018-05-03 Emendobio Inc. Compositions for genome editing
MX2019011215A (es) * 2017-03-24 2020-02-12 Curevac Ag Ácidos nucleicos que codifican proteínas asociadas a crispr y usos de los mismos.
KR20200124702A (ko) * 2018-02-23 2020-11-03 파이어니어 하이 부렛드 인터내쇼날 인코포레이팃드 신규한 cas9 오르소로그
US20220213456A1 (en) * 2019-04-30 2022-07-07 Emendobio Inc. Novel omni crispr nucleases
WO2021097271A1 (en) * 2019-11-15 2021-05-20 Assembly Biosciences, Inc. Compositions comprising bacterial species and methods related thereto
EP4259160A4 (en) * 2020-12-14 2025-05-14 Emendobio Inc. BIALLELIC INACTIVATION OF B2M
WO2022132756A1 (en) * 2020-12-14 2022-06-23 Emendobio Inc. Biallelic knockout of trac

Similar Documents

Publication Publication Date Title
US10988781B2 (en) Method of target cleaving using CRISPR hybrid DNA/RNA polynucleotides
FI3802807T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja menetelmiä niiden käyttämiseksi
JP2022531347A5 (cg-RX-API-DMAC7.html)
CN105886498A (zh) CRISPR-Cas9特异性敲除人PCSK9基因的方法以及用于特异性靶向PCSK9基因的sgRNA
WO2017181107A2 (en) Modified cpf1 mrna, modified guide rna, and uses thereof
CN104520429A (zh) 通过Cas9-crRNA复合物的RNA指导的DNA裂解
KR20160089530A (ko) Hbv 및 바이러스 질병 및 질환을 위한 crispr­cas 시스템 및 조성물의 전달,용도 및 치료적 적용
JP2016500262A5 (cg-RX-API-DMAC7.html)
KR20210008179A (ko) 올리고뉴클레오티드의 생성을 위한 신규한 방법
US20250223592A1 (en) Compositions and methods for circular rna affinity purification
JP2023508731A5 (cg-RX-API-DMAC7.html)
CN113950531A (zh) 使用m13噬菌体优化环状单链dna
WO2024140987A1 (en) Rna circularization
WO2014102688A1 (en) New design matrix for improvement of homology-directed gene targeting
CA3225082A1 (en) Enzymes with ruvc domains
EP1504119A2 (en) Method for ligating nucleic acids and molecular cloning
WO2024003810A1 (en) Guide rna with chemical modifications
CN120718906A (zh) 一种优化的ωRNA及其基因编辑应用
Weisbach et al. Multiplexed genome engineering with Cas12a
EP4606894A1 (en) Fusion protein containing cas protein and bacterial toxin and use thereof
WO2025140537A1 (en) Rna circularization
CN110885853A (zh) 构建多sgRNA表达载体的方法
JP7708752B2 (ja) 細菌パスツレラ・ニューモトロピカ(Рasteurella pneumotropica)由来Cas9タンパク質の使用
CN119193538A (zh) Cas9核酸酶及其应用
Maier et al. Meeting Report: German Genetics Society—Genome Editing with CRISPR.